BCL2 and non-small cell lung carcinoma: However, this proposal has not been validated across a panel of cells and cannot explain why a subpopulation of NSCLC cells with a low level of MCL-1 such as A549 are also resistant to BCL-2/BCL-xL/BCL-w inhibition (Fig. 2a and S2A).